Literature DB >> 9701730

Summary report on the ISOBM TD-6 workshop: analysis of 20 monoclonal antibodies against Sialyl Lewisa and related antigens. Montreux, Switzerland, September 19-24, 1997.

P D Rye1, N V Bovin, E V Vlasova, A A Molodyk, A Baryshnikov, F T Kreutz, W I Garinther, B C Schultes, A A Noujaim, R Madiyalakan, J Magnani, O Nilsson, K Nilsson, K Nustad, L Norum, H Bell, Y Cao, M R Suresh, D L Very, J V Freeman, K K Yeung, J Hilgers.   

Abstract

The ISOBM TD-6 Workshop is the first international workshop on monoclonal antibodies against the Sialyl Lewisa (SLea) antigen. Eight research groups participated in a blind study to characterize the epitope binding, relative affinity and performance in immunoradiometric assays, of a panel of 20 monoclonal antibodies. The antibodies were tested against a diverse panel of neoglycoconjugates, purified antigens and human serum pools from gastrointestinal malignancies. Epitope specificities were determined for the majority of antibodies in the panel. Cross-reactivity with related saccharide structures was noted in several antibodies. Overall, the results of the TD-6 Workshop show further development of SLea immunoassays may yield yet more specific assays for the detection and management of gastrointestinal and other malignancies.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9701730     DOI: 10.1159/000030032

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  3 in total

1.  Glycan motif profiling reveals plasma sialyl-lewis x elevations in pancreatic cancers that are negative for sialyl-lewis A.

Authors:  Huiyuan Tang; Sudhir Singh; Katie Partyka; Doron Kletter; Peter Hsueh; Jessica Yadav; Elliot Ensink; Marshall Bern; Galen Hostetter; Douglas Hartman; Ying Huang; Randall E Brand; Brian B Haab
Journal:  Mol Cell Proteomics       Date:  2015-03-02       Impact factor: 5.911

2.  Aberrant glycosylation associated with enzymes as cancer biomarkers.

Authors:  Danni L Meany; Daniel W Chan
Journal:  Clin Proteomics       Date:  2011-06-03       Impact factor: 3.988

3.  Definitive Characterization of CA 19-9 in Resectable Pancreatic Cancer Using a Reference Set of Serum and Plasma Specimens.

Authors:  Brian B Haab; Ying Huang; Seetharaman Balasenthil; Katie Partyka; Huiyuan Tang; Michelle Anderson; Peter Allen; Aaron Sasson; Herbert Zeh; Karen Kaul; Doron Kletter; Shaokui Ge; Marshall Bern; Richard Kwon; Ivan Blasutig; Sudhir Srivastava; Marsha L Frazier; Subrata Sen; Michael A Hollingsworth; Jo Ann Rinaudo; Ann M Killary; Randall E Brand
Journal:  PLoS One       Date:  2015-10-02       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.